Optimum Investment Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $166K | Hold |
260
| – | – | 0.07% | 206 |
|
|
2025
Q2 | $139K | Hold |
260
| – | – | 0.06% | 211 |
|
|
2025
Q1 | $109K | Hold |
260
| – | – | 0.05% | 232 |
|
|
2024
Q4 | $107K | Hold |
260
| – | – | 0.05% | 243 |
|
|
2024
Q3 | $131K | Hold |
260
| – | – | 0.06% | 239 |
|
|
2024
Q2 | $127K | Hold |
260
| – | – | 0.06% | 237 |
|
|
2024
Q1 | $140K | Hold |
260
| – | – | 0.06% | 228 |
|
|
2023
Q4 | $144K | Hold |
260
| – | – | 0.07% | 212 |
|
|
2023
Q3 | $114K | Hold |
260
| – | – | 0.06% | 248 |
|
|
2023
Q2 | $131K | Hold |
260
| – | – | 0.06% | 240 |
|
|
2023
Q1 | $130K | Hold |
260
| – | – | 0.07% | 228 |
|
|
2022
Q4 | $106K | Hold |
260
| – | – | 0.06% | 258 |
|
|
2022
Q3 | $85K | Hold |
260
| – | – | 0.05% | 303 |
|
|
2022
Q2 | $91K | Hold |
260
| – | – | 0.05% | 301 |
|
|
2022
Q1 | $142K | Hold |
260
| – | – | 0.06% | 266 |
|
|
2021
Q4 | $171K | Hold |
260
| – | – | 0.07% | 257 |
|
|
2021
Q3 | $162K | Sell |
260
-180
| -41% | -$121K | 0.07% | 258 |
|
|
2021
Q2 | $278K | Hold |
440
| – | – | 0.09% | 208 |
|
|
2021
Q1 | $215K | Hold |
440
| – | – | 0.06% | 251 |
|
|
2020
Q4 | $220K | Hold |
440
| – | – | 0.07% | 231 |
|
|
2020
Q3 | $173K | Hold |
440
| – | – | 0.06% | 247 |
|
|
2020
Q2 | $145K | Sell |
440
-50
| -10% | -$14.5K | 0.05% | 271 |
|
|
2020
Q1 | $119K | Sell |
490
-605
| -55% | -$158K | 0.05% | 283 |
|
|
2019
Q4 | $286K | Sell |
1,095
-50
| -4% | -$13.2K | 0.08% | 221 |
|
|
2019
Q3 | $311K | Sell |
1,145
-90
| -7% | -$25K | 0.1% | 206 |
|
|
2019
Q2 | $340K | Buy |
1,235
+172
| +16% | +$42.4K | 0.11% | 193 |
|
|
2019
Q1 | $238K | Buy |
1,063
+150
| +16% | +$31K | 0.08% | 249 |
|
|
2018
Q4 | $170K | Buy |
913
+335
| +58% | +$68.7K | 0.06% | 283 |
|
|
2018
Q3 | $144K | Sell |
578
-150
| -21% | -$36.4K | 0.04% | 346 |
|
|
2018
Q2 | $159K | Hold |
728
| – | – | 0.05% | 329 |
|
|
2018
Q1 | $139K | Buy |
+728
| New | +$134K | 0.04% | 342 |
|
|
2015
Q1 | $70K | Hold |
900
| – | – | 0.02% | 443 |
|
|
2014
Q4 | $67K | Hold |
900
| – | – | 0.02% | 440 |
|
|
2014
Q3 | $53K | Hold |
900
| – | – | 0.02% | 467 |
|
|
2014
Q2 | $60K | Hold |
900
| – | – | 0.02% | 442 |
|
|
2014
Q1 | $55K | Hold |
900
| – | – | 0.02% | 385 |
|
|
2013
Q4 | $48K | Buy |
900
+200
| +29% | +$10.5K | 0.02% | 401 |
|
|
2013
Q3 | $35K | Buy |
+700
| New | +$33.6K | 0.01% | 415 |
|
Other funds holding IDXX
Optimum Investment Advisors's IDXX Position: Q3 2025 in Review
Optimum Investment Advisors held its Idexx Laboratories (IDXX) position steady in Q3 2025 at 260 shares worth $166K. The position accounts for 0.07% of the portfolio, ranked #206.
Optimum Investment Advisors first reported a position in IDXX in Q3 2013 and has held it in 38 quarters since. The position peaked at $340K in Q2 2019. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.
- Optimum Investment Advisors held 260 shares of Idexx Laboratories worth $166K as of Q3 2025.
- Optimum Investment Advisors left its Idexx Laboratories share count unchanged in Q3 2025.
- Idexx Laboratories made up 0.07% of Optimum Investment Advisors's portfolio in Q3 2025, its #206 holding.
- Optimum Investment Advisors first reported a position in Idexx Laboratories in Q3 2013 and has held it in 38 quarters since.
- Optimum Investment Advisors's Idexx Laboratories position peaked at $340K in Q2 2019.
- 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.
Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.